Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. News
  7. Summary
    WEED   CA1380351009

CANOPY GROWTH CORPORATION

(WEED)
  Report
Delayed Toronto Stock Exchange  -  05/27 10:33:48 am EDT
5.990 CAD   -15.87%
10:34aCanopy Growth Aims to Turn Profit in Fiscal 2024 After Quarterly Results Miss Views on Cannabis Sales Weakness
MT
10:05aToronto index up as tech, cyclical stocks gain
RE
08:58aCANOPY GROWTH : Reports Fourth Quarter and Fiscal year 2022 Financial Results - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Piper Sandler Downgrades Canopy Growth to Underweight From Neutral, Price Target is $7

12/20/2021 | 07:57am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about CANOPY GROWTH CORPORATION
10:34aCanopy Growth Aims to Turn Profit in Fiscal 2024 After Quarterly Results Miss Views on ..
MT
10:05aToronto index up as tech, cyclical stocks gain
RE
08:58aCANOPY GROWTH : Reports Fourth Quarter and Fiscal year 2022 Financial Results - Form 8-K
PU
08:44aCanopy Growth reports Q4 net revenue down 25 per cent from year ago
AQ
07:40aCanopy Growth Down 11% in US Pre-Market as Reports Q4 Net Revenue Fell 25% YoY
MT
07:34aStocks Set for Weekly Gains as as US Futures Rise; Europe, Asia Stronger
MT
07:32aPot producer Canopy Growth posts wider core loss, shares slump
RE
07:28aCanopy Growth Fiscal Q4 Loss Narrows, Revenue Declines
MT
07:11aCANOPY GROWTH BRIEF : Company Expects to be Adjusted EBITDA Positive in FY2024 Excluding I..
MT
07:10aCANOPY GROWTH BRIEF : Reports Q4 Gross Margin Percentage of (142%); Adjusted Gross Margin ..
MT
More news
Analyst Recommendations on CANOPY GROWTH CORPORATION
More recommendations
Financials
Sales 2022 544 M 426 M 426 M
Net income 2022 100 M 78,4 M 78,4 M
Net Debt 2022 38,1 M 29,8 M 29,8 M
P/E ratio 2022 22,9x
Yield 2022 -
Capitalization 2 868 M 2 244 M 2 244 M
EV / Sales 2022 5,34x
EV / Sales 2023 5,35x
Nbr of Employees 3 259
Free-Float 63,8%
Chart CANOPY GROWTH CORPORATION
Duration : Period :
Canopy Growth Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANOPY GROWTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 21
Last Close Price 7,12 CAD
Average target price 9,92 CAD
Spread / Average Target 39,4%
EPS Revisions
Managers and Directors
David Eric Klein Chief Executive Officer & Non-Independent Director
Judy Hong Chief Financial Officer & VP-Investor Relations
Judy A. Schmeling Chairman
Ru Wadasinghe Chief Information Officer
Mark A. Ware Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CANOPY GROWTH CORPORATION-35.51%2 221
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.12.45%5 464
DONG-E-E-JIAO CO.,LTD.-36.37%2 964
TASLY PHARMACEUTICAL GROUP CO., LTD-34.38%2 306
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK10.98%1 972
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.-35.44%1 382